$28.13
Today
as of Oct 2, 16:46 ET
Last 30 days
Recent Press Releases & News
Avalyn Pharma (AVLN) Following AP02 Phase 1 Data Is Its Valuation Too Pricey
Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
AVLN earnings at a glance
The options market is pricing a move of about ±10.6% after the report, a range of roughly $25.15 to $31.11 from today's $28.13. Implied volatility is currently 68%. The share price of $28.13 sits in the middle of its 52-week range.
Overview
52-week range
$24
$40
25% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
68%
EM ±10.6% · $30 · Oct 16
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.98 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-21.83 | — | — | — | — | financials |
| Mon Jun 30, 2025 | Jun 2025 | $-17.63 | — | — | — | — | financials |
| Mon Mar 31, 2025 | Mar 2025 | $-63.24 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $-31M | $-28M | — | $-22M | $-19M |
| Net income | $-29M | $-27M | — | $-20M | $-18M |
| EPS (diluted) | $-0.98 | $-21.83 | — | $-17.63 | $-63.24 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $264M | $92M | $52M | — | — |
| Inventory | — | — | — | — | — |
| Total current assets | $358M | $130M | $144M | — | — |
| Total assets | $425M | $136M | $149M | — | — |
| Long-term debt | $15M | $15M | $0 | — | — |
| Total liabilities | $27M | $28M | $15M | — | — |
| Total equity | $398M | $-264M | $-239M | $-194M | $-192M |
Implied volatility — last 90 days
AVLN earnings FAQ
What is AVLN's expected move for earnings?
Options currently price a move of about ±10.6%, or $2.98 per share either way from $28.13.
What is AVLN's implied volatility?
AVLN's at-the-money implied volatility is about 68% based on the latest options snapshot.